As reported by the Senate Committee on the Judiciary on June 19, 2018
S. 2789 would primarily reauthorize activities of the Office of National Drug Control Policy (ONDCP) through 2022. Major programs administered by the office include the High-Intensity Drug Trafficking Areas program, National Youth Anti-Drug Media Campaign, the Drug-Free Communities program, and the Drug Court Program. In addition, S. 2789 would authorize grants to states to combat substance abuse.
Assuming appropriation of the specified and necessary amounts, CBO estimates that implementing S. 2789 would cost about $3.4 billion over the 2019-2023 period. Of that total, $1.1 billion would be for the High-Intensity Drug Trafficking Areas program, about $0.9 billion would be for the National Youth Anti-Drug Media Campaign, and $0.5 billion would be for grants to supplement Medicaid reimbursements for professionals who provide treatment for substance use disorders.
Enacting the bill would affect direct spending because it would allow ONDCP to accept and spend monetary gifts; therefore, pay-as-you-go procedures apply. However, CBO estimates that the net effect on direct spending would be negligible. Enacting S. 2789 would not affect revenues.
CBO estimates that enacting S. 2789 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2029.
S. 2789 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.